Surgery – Means for introducing or removing material from body for... – Infrared – visible light – ultraviolet – x-ray or electrical...
Patent
1988-03-16
1990-10-30
Rosenbaum, C. Fred
Surgery
Means for introducing or removing material from body for...
Infrared, visible light, ultraviolet, x-ray or electrical...
604 49, 514912, A61N 130, A61M 3100
Patent
active
049665774
ABSTRACT:
Disclosed is a composition for preventing secondary cataract formation in the eye following removal of the lens, comprising an antibody specific to particular lens cells related to secondary cataract formation, which antibody is conjugated to an antiproliferative agent. The particularly preferred antiproliferative agents require activation after binding of the antibody to the target cells, and activation may be accomplished by addition of a second composition or by exposure of the eye to electromagnetic energy.
Also disclosed is a method of using the composition by administering it directly to the site from which the lens was removed to kill or prevent proliferation of lens cells.
REFERENCES:
patent: 4363758 (1982-12-01), Musuko et al.
patent: 4432751 (1984-02-01), Emery et al.
patent: 4657930 (1987-04-01), Emery et al.
patent: 4665089 (1987-05-01), Siezen et al.
patent: 4778815 (1988-10-01), Cash
patent: 4778828 (1988-10-01), Palmai et al.
patent: 4797422 (1989-01-01), Testa
patent: 4826872 (1989-05-01), Terao et al.
patent: 4871350 (1989-10-01), Lam
Heath et al., "Antibody-Targeted Liposomes: Increase in Specific Toxicity of Methotrexate .gamma.-Aspartate", Proc. Natl. Sci., vol. 80, 3/83, 1377-1381.
Campbell, "Monoclonal Antibody Technology," Laboratory Techniques in Biochemistry and Molecular Biology, vol. 13, pp. 16-25.
Cole et al., "Enzymatic Zonulolysis and Cryoextraction of Cataracts", International Surgery, Sep. 1968, vol. 50, No. 3, pp. 242-244.
Kincses et al., "Experimental Production of Antibodies Against Cataractous Human Lens", Acta Medica Acad. Sci., vol. 31(1-2), pp. 9-13 (1974).
Russell et al., "The Development of a Monoclonal Antibody to a Human Gamma Crystallin", Current Eye Research, vol. 3, No. 11, 1984, pp. 1329-1335.
Nissen et al., "Antibodies to Lens Antigens in Cataract and After Cataract Surgery", British J. of Ophthal., vol. 65, 1981, pp. 63-66.
Mulders et al., Curr. Eye Res., 7: 207 (1988).
Avrameas et al., Immunochemistry 8: 1175-1179 (1971).
Nakane et al., Jour. of Histochem. Cytochem. 22: 1084-1091 (1974).
Monji et al., Biochem. Biophs. Res. Comm. 85: 671 (1978).
Deguchi, T. et al., Cancer Res. 46: 3751-3755 (1986).
Ghose, T. et al., Europe J. Cancer 11: 321-326 (1975).
Youle, R. et al., Proc. Nat'l. Acad. Sci. USA 77: 5483-5486 (1980).
Hurwitz, E. et al., Cancer Res. 35: 1175-1181 (1975).
Mills, S. et al., Hybridoma 5: 265-275 (1986).
Pimm, M. et al., Int. J. Cancer 30: 75 (1982).
Paul and Goodenough, J. Cell. Biol. 96: 625 (1983).
Fazekas et al., J. Immunol. Methods 35: 1 (1980).
Barton Beverly E.
Crosson Craig E.
Garner William H.
Gwon Arlene E.
Allergan Inc.
Rose Sharon
Rosenbaum C. Fred
LandOfFree
Prevention of lens-related tissue growth in the eye does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prevention of lens-related tissue growth in the eye, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prevention of lens-related tissue growth in the eye will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-273022